Biodexa Pharmaceuticals PLC (BDRX)
4.57
+0.17
(+3.86%)
USD |
NASDAQ |
Nov 22, 16:00
4.78
+0.21
(+4.60%)
After-Hours: 20:00
Biodexa Pharmaceuticals Price to Book Value: 0.2405 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 0.2405 |
| November 21, 2024 | 0.2315 |
| November 20, 2024 | 0.2026 |
| November 19, 2024 | 0.1889 |
| November 18, 2024 | 0.192 |
| November 15, 2024 | 0.1905 |
| November 14, 2024 | 0.2557 |
| November 13, 2024 | 0.2552 |
| November 12, 2024 | 0.2641 |
| November 11, 2024 | 0.271 |
| November 08, 2024 | 0.2831 |
| November 07, 2024 | 0.2876 |
| November 06, 2024 | 0.3041 |
| November 05, 2024 | 0.2962 |
| November 04, 2024 | 0.2989 |
| November 01, 2024 | 0.311 |
| October 31, 2024 | 0.3236 |
| October 30, 2024 | 0.3262 |
| October 29, 2024 | 0.3504 |
| October 28, 2024 | 0.3425 |
| October 25, 2024 | 0.332 |
| October 24, 2024 | 0.3481 |
| October 23, 2024 | 0.372 |
| October 22, 2024 | 0.3283 |
| October 21, 2024 | 0.3146 |
| Date | Value |
|---|---|
| October 18, 2024 | 0.2999 |
| October 17, 2024 | 0.3089 |
| October 16, 2024 | 0.442 |
| October 15, 2024 | 0.2636 |
| October 14, 2024 | 0.2752 |
| October 11, 2024 | 0.2762 |
| October 10, 2024 | 0.2604 |
| October 09, 2024 | 0.252 |
| October 08, 2024 | 0.2957 |
| October 07, 2024 | 0.3136 |
| October 04, 2024 | 0.292 |
| October 03, 2024 | 0.3161 |
| October 02, 2024 | 0.367 |
| October 01, 2024 | 0.4025 |
| September 30, 2024 | 0.3712 |
| September 27, 2024 | 0.3783 |
| September 26, 2024 | 0.388 |
| September 25, 2024 | 0.3836 |
| September 24, 2024 | 0.385 |
| September 23, 2024 | 0.3602 |
| September 20, 2024 | 0.3842 |
| September 19, 2024 | 0.4814 |
| September 18, 2024 | 0.4901 |
| September 17, 2024 | 0.5012 |
| September 16, 2024 | 0.5263 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1834
Minimum
Mar 31 2023
7.895
Maximum
Jul 09 2021
1.870
Average
0.9371
Median
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 2.116 |
| NuCana PLC | 0.5749 |
| TC BioPharm (Holdings) PLC | 0.2262 |
| Autolus Therapeutics PLC | 1.640 |
| Verona Pharma PLC | 24.34 |
Price to Book Value Related Metrics
| PS Ratio | 4.121 |
| Price | 4.57 |
| Earnings Yield | -1.63K% |
| Market Cap | 2.654M |